| NDC Code: |
0555-0725 |
| Proprietary Name: |
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride |
| Suffix: |
|
| Non-Proprietary Name: |
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride |
| Dosage Form: |
TABLET, MULTILAYER, EXTENDED RELEASE |
| Method: |
ORAL |
| Original Marketing Date: |
11-02-2011 |
| Category Name: |
ANDA |
| Application Number: |
ANDA076236 |
| Labeler: |
BARR LABORATORIES INC. |
| Substance Name: |
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Active Numerator Strength: |
60; 120 |
| Active Ingredient Unit: |
mg/1; mg/1 |
| Pharm Classes: |
Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
| DEA Schedule: |
|
